Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial

por Emara, Moataz Maher, Elsawy, Neamat Hamdy, Abdelaaty, Kholoud M., Elhamaky, Amal Salah, Eltahan, Naglaa Hamdi
Publicado 2022